Though mTOR is a key pathway for cyst growth, mTOR inhibitors are not recommended for treating ADPKD because of various side effects noted in clinical trials, including interfering with normal recovery from injury (Torres et al., 2010). This evidence concerns the gene MTOR and cyst.